Vis enkel innførsel

dc.contributor.authorNguyen, Chinh Bkrong Thi Thuy
dc.contributor.authorAlsøe, Lene
dc.contributor.authorLindvall, Jessica Margareta
dc.contributor.authorSulheim, Dag
dc.contributor.authorFagermoen, Frode Even
dc.contributor.authorWinger, Anette
dc.contributor.authorKaarbø, Mari
dc.contributor.authorNilsen, Hilde
dc.contributor.authorWyller, Vegard Bruun Bratholm
dc.date.accessioned2018-05-04T12:35:46Z
dc.date.available2018-05-04T12:35:46Z
dc.date.created2017-08-30T15:10:16Z
dc.date.issued2017
dc.identifier.citationJournal of Translational Medicine. 2017, 15:102 1-21.nb_NO
dc.identifier.issn1479-5876
dc.identifier.urihttp://hdl.handle.net/11250/2497211
dc.description.abstractBackground Chronic fatigue syndrome (CFS) is a prevalent and disabling condition affecting adolescents. The pathophysiology is poorly understood, but immune alterations might be an important component. This study compared whole blood gene expression in adolescent CFS patients and healthy controls, and explored associations between gene expression and neuroendocrine markers, immune markers and clinical markers within the CFS group. Methods CFS patients (12–18 years old) were recruited nation-wide to a single referral center as part of the NorCAPITAL project. A broad case definition of CFS was applied, requiring 3 months of unexplained, disabling chronic/relapsing fatigue of new onset, whereas no accompanying symptoms were necessary. Healthy controls having comparable distribution of gender and age were recruited from local schools. Whole blood samples were subjected to RNA sequencing. Immune markers were blood leukocyte counts, plasma cytokines, serum C-reactive protein and immunoglobulins. Neuroendocrine markers encompassed plasma and urine levels of catecholamines and cortisol, as well as heart rate variability indices. Clinical markers consisted of questionnaire scores for symptoms of post-exertional malaise, inflammation, fatigue, depression and trait anxiety, as well as activity recordings. Results A total of 29 CFS patients and 18 healthy controls were included. We identified 176 genes as differentially expressed in patients compared to controls, adjusting for age and gender factors. Gene set enrichment analyses suggested impairment of B cell differentiation and survival, as well as enhancement of innate antiviral responses and inflammation in the CFS group. A pattern of co-expression could be identified, and this pattern, as well as single gene transcripts, was significantly associated with indices of autonomic nervous activity, plasma cortisol, and blood monocyte and eosinophil counts. Also, an association with symptoms of post-exertional malaise was demonstrated. Conclusion Adolescent CFS is characterized by differential gene expression pattern in whole blood suggestive of impaired B cell differentiation and survival, and enhanced innate antiviral responses and inflammation. This expression pattern is associated with neuroendocrine markers of altered HPA axis and autonomic nervous activity, and with symptoms of post-exertional malaise.nb_NO
dc.language.isoengnb_NO
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.subjectChronic fatigue syndromenb_NO
dc.subjectAdolescentnb_NO
dc.subjectGene expressionnb_NO
dc.subjectInflammationnb_NO
dc.subjectB cell differentiationnb_NO
dc.subjectB cell survivalnb_NO
dc.titleWhole blood gene expression in adolescent chronic fatigue syndrome: An exploratory cross-sectional study suggesting altered B cell differentiation and survivalnb_NO
dc.typeJournal articlenb_NO
dc.typePeer reviewednb_NO
dc.description.versionpublishedVersionnb_NO
dc.rights.holder© The Author(s) 2017. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/ publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.nb_NO
dc.source.pagenumber1-21nb_NO
dc.source.volume15:102nb_NO
dc.source.journalJournal of Translational Medicinenb_NO
dc.identifier.doi10.1186/s12967-017-1201-0
dc.identifier.cristin1489980
cristin.unitcode1991,6,3,0
cristin.unitnameAvd Barn
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal